Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers.
about
Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysisHypermethylation of the caveolin-1 gene promoter in prostate cancer.Down-regulation of Cdc6, a cell cycle regulatory gene, in prostate cancer.Epigenetic changes in prostate cancer: implication for diagnosis and treatment.Cytogenetics and molecular genetics of cancer of the prostate.Expression of p16 gene and Rb protein in gastric carcinoma and their clinicopathological significanceAberrant DNA methylation and prostate cancer.Prostate cancer epigenetics: a review on gene regulation.Promoter hypermethylation in prostate cancer.The AR dependent cell cycle: mechanisms and cancer relevance.Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model.Notl-Msell methylation-sensitive amplied fragment length polymorhism for DNA methylation analysis of human cancers.Demethylase activity is directed by histone acetylation.Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomasDNA methylation in promoter region as biomarkers in prostate cancer.Identification of key pathways and genes with aberrant methylation in prostate cancer using bioinformatics analysisDNA hypermethylation status of multiple genes in prostate adenocarcinomas.Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA).
P2860
Q24673086-84CF39B6-D42C-42CB-83AB-2159B585503CQ30979021-6A36B6E2-7416-43C0-9F1D-050E50C78B76Q32107802-5C097E03-8012-49F0-AE98-8522FFB83944Q34385658-7453B8E9-5D0B-444B-92E1-6FA818A4851CQ34984193-2CBFA1E5-A727-4647-83B7-6998ACAC476DQ35010835-B3BF6A3A-D854-44A9-B700-AA446F97C9F0Q35560819-09915CD4-2456-42B3-AC65-BC66ADF113A1Q37380585-7BCB7036-7273-4A68-AC2E-0644480DACC1Q37791396-94D20661-666A-4580-BA93-3D94114CD318Q37904028-063F76D6-7E84-405F-BC2F-0147D0FD107BQ39528169-D5A76369-79AD-477D-9375-B1D1FEC12764Q40695944-2D49AE32-C3E9-41E1-8153-0534417E9C97Q40783486-025F7CD6-26BF-4EA7-8745-8F2E7EADE8D0Q42048106-1794F97B-D4E0-4DDB-824B-D82F2C840E92Q42261678-86AB7227-8B25-436A-B416-CB7D4B5BE674Q42687929-FC6282F9-42A9-42C4-A57C-BD13DA81501CQ44083581-27970D9A-0D0B-4584-B49D-08670C633062Q51737212-CACCDB51-1B82-40FD-B7D9-14A8CD9C5D92
P2860
Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Analysis of cyclin-dependent k ...... rns in human prostate cancers.
@en
type
label
Analysis of cyclin-dependent k ...... rns in human prostate cancers.
@en
prefLabel
Analysis of cyclin-dependent k ...... rns in human prostate cancers.
@en
P2093
P2860
P1433
P1476
Analysis of cyclin-dependent k ...... rns in human prostate cancers.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0045(20000515)43:3<233::AID-PROS10>3.0.CO;2-S
P577
2000-05-01T00:00:00Z